Table of Contents

company-logo

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The firm undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Its additional projects, such as HF0220 for neuroprotection, NW-3509 for the treatment of schizophrenia, as well as pruvanserin and sarizotan for treatment of CNS diseases, are at various stages of preclinical and clinical development.

Newron Pharmaceuticals SpA Dividend Announcement

• Newron Pharmaceuticals SpA does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Newron Pharmaceuticals SpA dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Newron Pharmaceuticals SpA Dividend History

Newron Pharmaceuticals SpA Dividend Yield

Newron Pharmaceuticals SpA current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Newron Pharmaceuticals SpA stock? Use our calculator to estimate your expected dividend yield:

Newron Pharmaceuticals SpA Financial Ratios

P/E ratio-7.61
PEG ratio1.48
P/B ratio-4.65
ROE61.99%
Payout ratio0.00%
Current ratio3.73
Quick ratio3.73
Cash Ratio1.47

Newron Pharmaceuticals SpA Dividend FAQ

Does Newron Pharmaceuticals SpA stock pay dividends?
Newron Pharmaceuticals SpA does not currently pay dividends to its shareholders.
Has Newron Pharmaceuticals SpA ever paid a dividend?
No, Newron Pharmaceuticals SpA has no a history of paying dividends to its shareholders. Newron Pharmaceuticals SpA is not known for its dividend payments.
Why doesn't Newron Pharmaceuticals SpA pay dividends?
There are several potential reasons why Newron Pharmaceuticals SpA would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Newron Pharmaceuticals SpA ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Newron Pharmaceuticals SpA has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Newron Pharmaceuticals SpA a dividend aristocrat?
Newron Pharmaceuticals SpA is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Newron Pharmaceuticals SpA a dividend king?
Newron Pharmaceuticals SpA is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Newron Pharmaceuticals SpA a dividend stock?
No, Newron Pharmaceuticals SpA is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Newron Pharmaceuticals SpA stocks?
To buy Newron Pharmaceuticals SpA you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Newron Pharmaceuticals SpA stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.